Paget's Disease of Bone: Osteoimmunology and Osteoclast Pathology

被引:15
|
作者
Rabjohns, Emily M. [1 ]
Hurst, Katlyn [2 ]
Ghosh, Arin [2 ]
Cuellar, Maria C. [3 ]
Rampersad, Rishi R. [1 ]
Tarrant, Teresa K. [1 ]
机构
[1] Duke Univ, Dept Med, Div Rheumatol & Immunol, DUMC 3874,200 Trent Dr, Durham, NC 27710 USA
[2] Duke Univ, Durham, NC USA
[3] Hosp Salvador, Div Rheumatol, Dept Med, Santiago, Chile
关键词
Paget's disease of bone; Osteoimmunology; Osteoclast; Chemokines; Chemokine receptor; Optineurin; Bisphosphonate;
D O I
10.1007/s11882-021-01001-2
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of ReviewThe purpose of this review is to recognize clinical features of Paget's disease of bone and to describe how the osteoclast, a myeloid-derived cell responsible for bone resorption, contributes to the disease.Recent FindingsRecent studies have identified several variants in SQSTM1, OPTN, and other genes that may predispose individuals to Paget's disease of bone; studies of these genes and their protein products have elucidated new roles for these proteins in bone physiology.SummaryUnderstanding the pathologic mechanisms in the Pagetic osteoclast may lead to the identification of future treatment targets for other inflammatory and autoimmune diseases characterized by abnormal bone erosion and/or osteoclast activation.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Paget's disease of the bone
    Zargar, AH
    Laway, BA
    Masoodi, SR
    Wani, AI
    Bashir, MI
    Tramboo, NA
    Khan, FA
    SAUDI MEDICAL JOURNAL, 1999, 20 (08) : 629 - 632
  • [32] Paget's disease of bone
    Siris, ES
    JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (07) : 1061 - 1065
  • [33] Paget's disease of bone
    Jaffe, HL
    ARCHIVES OF PATHOLOGY, 1933, 15 (01): : 83 - 131
  • [34] Paget's Disease of Bone
    Ralston, Stuart H.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (07): : 644 - 650
  • [35] Treatment of Paget's disease - Taming the wild osteoclast
    Deftos, LJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (09): : 872 - 875
  • [36] NFAM1 signaling enhances osteoclast formation and bone resorption activity in Paget's disease of bone
    Sambandam, Yuvaraj
    Sundaram, Kumaran
    Saigusa, Takamitsu
    Balasubramanian, Sundaravadivel
    Reddy, Sakamuri V.
    BONE, 2017, 101 : 236 - 244
  • [37] Increased nucleolar organizer regions (AgNORs) in osteoclast nuclei of Paget's bone disease.
    Chappard, D
    Basle, MF
    Audran, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M754 - M754
  • [38] ROLE OF THE ENDOVANILLOID/ENDOCANNABINOID SYSTEM IN THE MODULATION OF OSTEOCLAST ACTIVITY IN INDIVIDUALS WITH PAGET'S DISEASE OF BONE
    Paoletta, M. P.
    Liguori, S. L.
    Moretti, A. M.
    Iolascon, G. I.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S165 - S165
  • [39] BONE Do all Paget disease risk genes incriminate the osteoclast?
    Singer, Frederick R.
    Leach, Robin J.
    NATURE REVIEWS RHEUMATOLOGY, 2010, 6 (09) : 502 - 503
  • [40] Bone Quality in Paget’s Disease of Bone
    Frederick R. Singer
    Current Osteoporosis Reports, 2016, 14 : 39 - 42